课题基金 / 基金详情

Developing Novel Therapeutic Targets for Heart Failure

Developing Novel Therapeutic Targets for Heart Failure
开发心力衰竭的新治疗靶点
批准号：
334655
负责人：
Liu Peter P
金额：
$38.25万
依托单位：
University of Ottawa Heart Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-09-01 至 2020-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=334655&lang=en
关键词：
Aging Heart Failure Target Validation Therapy

项目摘要

项目成果

Liu Peter P的其他基金

相似基金

相关文献

中文摘要
翻译
目前许多心力衰竭治疗仍然无效，导致许多患者死亡和不必要的痛苦。我们已经开发了一种大规模的蛋白质发现技术，以促进心力衰竭和poss的新原因的识别
英文摘要
Much of heart failure treatment today is still ineffective, leading to many dying patients and unnecessary suffering. We have developed a large scale protein discovery technology to facilitate the identification of novel causes of heart failure, and poss
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The COVID-R3ICSAB Study: COVID-19 Wide Impact: Research on the Risk and Resilience In Special Communities of Chinese, South Asian and Black Populations
COVID-19 Variant Supplement - Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)
Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
海外基金